The Anticancer Activity of Five Species of Artemisia on Hep2 and HepG2 Cell Lines

Seyed Ahmad Emami, Nasser Vahdati-Mashhadian, Remisa Vosough, I. R. Iran

2009 · 33 citations · 15 references

Concepts

Abstract

Summary It has been reported that several Artemisia species (Astraceae) possess cytotoxic activity against different human cell lines. In this study, the toxicity of the A. kulbadica, A. sieberi, A. turanica, A. santolina and A. diffusa against human Caucasian hepatocyte carcinoma (HepG-2) and human Caucasian larynx carcinoma (Hep-2) cell lines have been investigated. These plants were collected from Khorasan province, northeast of Iran. Different concentrations (200, 400, 600, 800, 1000, 1200, 1600 and 3200 µg/mL) of ethanol extract of each sample were prepared. The cytotoxic effects of these concentrations against two human tumor cell lines Hep2 and HepG2 were determined by quantitative MTT assay. Results showed concentration- and time-dependent toxicity. In all extracts, toxic effects were significantly higher on HepG2 cells compared with Hep2 cells. HepG2 cells are rich in phase I and phase II metabolic enzymes and it is probable that metabolic activation of some active ingredients of the extracts were converted to more toxic metabolites and caused more toxicity in these cells.

References

15